Hikari Tsushin Inc’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Hold
1,373
0.02% 68
2025
Q4
$232K Hold
1,373
0.02% 69
2025
Q3
$198K Hold
1,373
0.01% 70
2025
Q2
$174K Hold
1,373
0.01% 71
2025
Q1
$176K Hold
1,373
0.01% 67
2024
Q4
$182K Hold
1,373
0.01% 67
2024
Q3
$200K Hold
1,373
0.01% 66
2024
Q2
$188K Hold
1,373
0.01% 64
2024
Q1
$188K Hold
1,373
0.02% 60
2023
Q4
$187K Hold
1,373
0.02% 57
2023
Q3
$168K Hold
1,373
0.02% 55
2023
Q2
$174K Hold
1,373
0.02% 54
2023
Q1
$177K Hold
1,373
0.02% 54
2022
Q4
$180K Hold
1,373
0.02% 54
2022
Q3
$161K Hold
1,373
0.02% 50
2022
Q2
$162K Hold
1,373
0.02% 50
2022
Q1
$179K Buy
+1,373
New +$179K 0.02% 45
2020
Q1
Sell
-4,380
Closed -$528K 42
2019
Q4
$528K Hold
4,380
0.09% 38
2019
Q3
$436K Hold
4,380
0.09% 40
2019
Q2
$478K Hold
4,380
0.1% 41
2019
Q1
$490K Hold
4,380
0.11% 43
2018
Q4
$422K Hold
4,380
0.1% 44
2018
Q3
$534K Hold
4,380
0.12% 41
2018
Q2
$481K Hold
4,380
0.12% 38
2018
Q1
$468K Buy
+4,380
New +$486K 0.12% 40
2016
Q4
Sell
-28,500
Closed -$2.75M 29
2016
Q3
$2.75M Hold
28,500
0.72% 21
2016
Q2
$2.44M Buy
+28,500
New +$2.56M 0.6% 25

Other funds holding IBB

Hikari Tsushin Inc's IBB Position: Q1 2026 in Review

Hikari Tsushin Inc held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,373 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #68.

Hikari Tsushin Inc first reported a position in IBB in Q2 2016 and has held it in 27 quarters since. The position peaked at $2.75M in Q3 2016. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Hikari Tsushin Inc held 1,373 shares of iShares Biotechnology ETF worth $232K as of Q1 2026.
  • Hikari Tsushin Inc left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.02% of Hikari Tsushin Inc's portfolio in Q1 2026, its #68 holding.
  • Hikari Tsushin Inc first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 27 quarters since.
  • Hikari Tsushin Inc's iShares Biotechnology ETF position peaked at $2.75M in Q3 2016.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Hikari Tsushin Inc's 13F filing for Q1 2026, filed 13 May 2026.